Locally Advanced Or Metastatic Gastro Intestinal Carcinoma clinical trials

Explore recruiting locally advanced or metastatic gastro intestinal carcinoma clinical trials.

Recruiting locally advanced or metastatic gastro intestinal carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Or Metastatic Gastro Intestinal Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Exploratory Study of CAPEcitabine pharmacokinetics and hand-foot syndrome in CES1 variant carriers: the ESCAPE study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Locally Advanced Or Metastatic Gastro Intestinal Carcinoma trials by city

Locally Advanced Or Metastatic Gastro Intestinal Carcinoma clinical trials

Recruiting locally advanced or metastatic gastro intestinal carcinoma studies right now

Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Also recruiting in Europe

Exploratory Study of CAPEcitabine pharmacokinetics and hand-foot syndrome in CES1 variant carriers: the ESCAPE study

Locally Advanced Or Metastatic Gastro Intestinal Carcinoma trials by city

Other conditions